APA (7th ed.) Citation

Xie, C., Chang, J., Hao, X., Yu, J., Liu, H., & Sun, X. (2013). Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel. European Journal of Pharmaceutics & Biopharmaceutics, 85(3 Part A), 541. https://doi.org/10.1016/j.ejpb.2013.06.008

Chicago Style (17th ed.) Citation

Xie, Cheng, Jun Chang, Xiao-Dong Hao, Jian-Ming Yu, Hong-Rui Liu, and Xun Sun. "Mitochondrial-targeted Prodrug Cancer Therapy Using a Rhodamine B Labeled Fluorinated Docetaxel." European Journal of Pharmaceutics & Biopharmaceutics 85, no. 3 Part A (2013): 541. https://doi.org/10.1016/j.ejpb.2013.06.008.

MLA (9th ed.) Citation

Xie, Cheng, et al. "Mitochondrial-targeted Prodrug Cancer Therapy Using a Rhodamine B Labeled Fluorinated Docetaxel." European Journal of Pharmaceutics & Biopharmaceutics, vol. 85, no. 3 Part A, 2013, p. 541, https://doi.org/10.1016/j.ejpb.2013.06.008.